Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Eargo To Contact Him Directly To Discuss Their Options
NEW YORK, NY - 
(NewMediaWire) - October 03, 2021 - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Eargo, Inc. (“Eargo” or the “Company”) (NASDAQ: EAR).
If you suffered losses exceeding $50,000 investing in Eargo stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: http://www.faruqilaw.com/EAR.
There is no cost or obligation to you.
Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Delaware, Pennsylvania, California and Georgia.
On September 22, 2021, after market hours, Eargo disclosed that “it is the target of a criminal investigation by the U.S. Department of Justice (the ‘DOJ’) related to insurance reimbursement claims the Company has submitted on behalf of its customers covered by federal employee health plans.” The Company further stated that “[a]s previously disclosed, the Company has been the subject of an ongoing claims audit by an insurance company that is the Company’s largest third-party payor. The Company has been informed by the insurance company that the DOJ is now the principal contact related to the subject matter of the audit.” Finally, the Company announced that it “is withdrawing its financial guidance for the fiscal year ending December 31, 2021.”
On this news, Eargo’s shares fell over 65% during after-hours trading on September 22, 2021 and trading September 23, 2021, damaging investors.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
